FDA wants easier-to-understand Rx drug print ads
This article was originally published in Scrip
Executive Summary
In a policy shift, the FDA is calling on pharmaceutical manufacturers to make risk information in their print advertisements and promotions easier for consumers to understand – directing companies in a newly revised draft guidance how to accomplish that feat.